US Patent 11339170 Spiropyrrolidine derived antiviral agents
Patent 11339170 was granted and assigned to Enanta Pharmaceuticals on May, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 20, 2021
0
Date of Patent
May 24, 2022
0
Patent Applicant
Patent Application Number
17479455
0
Patent Citations
•••
Patent Citations Received
Patent Inventor Names
Ruichao Shen
0
Guoqiang Wang
0
Hui Cao
0
Jiajun Zhang
0
Jorden Kass
0
Wei Li
0
Xiaowen Peng
0
Xuri Gao
0
Yat Sun Or
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11339170 Spiropyrrolidine derived antiviral agents
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.